Global trends in the health economics field of PD-1/PD-L1 inhibitors: A bibliometric and visualized study

Inhibitors of programmed cell death protein 1 and its associated ligand (PD-L1) are widely used in cancer treatment. However, medical costs and benefits of PD-1/PD-L1 inhibitors need attention owing to differences in response rates among individuals. This study explored global trends in the health e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Sicen, Xu, Licong, Zhang, Liang, Peng, Lanyuan, Li, Yixin, Liu, Yuancheng, Yu, Nianzhou, Chen, Wangqing, Huang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073662/
https://www.ncbi.nlm.nih.gov/pubmed/37033602
http://dx.doi.org/10.3389/fphar.2023.1141075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073662/
https://www.ncbi.nlm.nih.gov/pubmed/37033602
http://dx.doi.org/10.3389/fphar.2023.1141075

Ejemplares similares